展品10.4

2024年10月23日

Oaktree Acquisition Corp. III Life Sciences

333 South Grand Avenue, 28th Floor

洛杉磯，加州90071

 

回信：

首次公開募股(IPO)

女士，先生們：

本信（本“協議”）是按照擬建能源收購有限公司（源能收購）與J.P. Morgan Securities LLC和b of A Securities, Inc.作為代表（“承銷商”）之間簽訂的承銷協議（“協議”）要求而交付給您的，涉及一項最多可達28,750,000小公司單位的承銷首次公開招股（“發行”），其中包括最多3,750,000小公司單位可以購買以覆蓋超額配售（如有）（“單位”），每個單位由一個普通A級股份（每股股票價值為0.0001美元）（“普通股”）和一半可贖回認股權組成。每個完整的認股權證（“公開認股權證”）授予持有人購買一個普通股，每股股價為11.50美元，如招股說明書（如下文定義）中所述，股價會進行調整。單位將根據擬建能源收購有限公司向美國證券交易委員會提交的S-1表格註冊聲明和招股說明書（“招股說明書”）在公開發行中出售，公司已申請在納斯達克全球市場上市。這裡使用的某些大寫詞語在本文第1段中有定義。限制條款）根據承銷協議（「承銷協議」）之間由Oaktree Acquisition Corp. III Life Sciences, 一家開曼群島免稅公司（「權益代理」和Jefferies LLC、花旗全球貨幣市場股 corp 和瑞銀證券股 corp 為代表（「代表人在其中列明的承銷商（「承銷商」，涉及一次承銷首次公開發行（即 「公開發售(以下稱"公開發售")」最多20,125,000股公司單位（包括根據承銷協議條款可購買的2,625,000股單位，每個這樣的單位由一股A類普通股組成，每股面值$0.0001（「普通股和 五分之一 憑可贖回認股權以購買一份普通股，根據認股權協議規定（該“認股權證協議”）與大陸股票轉倉信託公司作為認股權代理所訂定，在公開發售完成時（這些單位，該“公開單位”）。公開買賣單位將根據表格 S-1 和招股說明書（該 “招股書註冊聲明和招股說明書（“說明書”）」提交給美國證券交易委員會（「”). Certain capitalized terms used herein are defined in paragraph 1 這裡。

In order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the Public Offering and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Oaktree Acquisition Holdings III LS, LLC (the “贊助商”) and each of the undersigned (each, an “內部人士其他父母公司子公司在為其他有價值的考慮下的情況下，為了促使公司和承銷商簽署承銷協議，進行公開發行以及出於其他良好的金錢考慮，Smilodon Capital，LLC，一家特定負責有限責任公司，以及公司董事會和/或管理團隊的成員（每位簽署人，皆為“公司內部人士”）在此同意以下事項：本人與公司如下協議：

1. 定義。如本文件所述，“業務合併”指的是與一個或多個企業或實體進行的合併、交換股份、資產收購、股份購買、重組或類似的業務組合；（ii）“創始人股份”指的是在完成公開發行之前已發行的公司普通B類股份，每股面值為0.0001美元。定向增發基金單元”指的是由贊助商購買的單位，總價為550萬美元（如果承銷商行使購買額外公開單位的選擇權，最高為602.5萬美元），這些單位將在與公開發行同時結束的私募中完成。定向增發認股權”指的是包含在私募單位中的認股權證，其條款受認股權證協議管轄。公開發售股東”指的是最初包含在公開發行中發行的公共單位中的普通股持有人，或者是在公開發行中發行但尚未分開的公共單位的持有人。公開股份「標的股」指的是在公開發售中出售的公開單位的一部分發行的普通股；(vii)「信託帳戶”應當是指

須存入公開發行及出售私募投資單位的部分淨收益的信託帳戶；(viii)」轉移」應該 指 (a) 出售、提供出售、合約或協議出售、合約或協議、投保、授出任何購買或以其他方式出售的選擇權，或協議直接或間接出售，或建立或增加售 根據修訂後的 1934 年證券交易法第 16 條所指的認購對等頭寸或減少的同等狀況或清盤，以及委員會的規則及規例公布 根據其中，有關任何證券、(b) 進行任何交換或其他安排，全部或部分轉讓給他人，任何證券擁有權所產的經濟後果，無論該等交易是否要結算 以現金或以其他方式交付該等證券，或 (c) 公開宣布實施第 (a) 或 (b) 條指明的任何交易意圖；及 (ix)」憲章」指本公司的修訂 以及重新修訂的公司章程大綱及章程細則，可能會不時修改。

2. 表示 及保固.

(a) 贊助商及每位內部人士，就本身或本人而言，聲明並保證 該公司擁有完整權利和權力，而不違反其受約束的任何協議（包括但不限於任何 非競爭 或者 非招募 與任何僱主或前僱主的協議），以簽訂本信函協議，並在適用情況下擔任本公司的主任和/或公司董事會的董事 董事 (」董事會」)，視適用情況而定，每位內人同意在招股章程、道路展及任何其他資料中被列為本公司的主任及/或董事，或作為私募投資者的購買者 單位 (視適用情況而定)。

(b) 每位同時是本公司董事或主任的內部人士代表及認證，以 尊重自己，該等 Insider 向本公司提供的傳記資料（包括說明書中的任何此類信息）在所有重要方面都是真實和準確的，並且不忽略任何重要性 有關該內人背景的資料。此類 Insider 向本公司提供的問卷在所有重要方面都是真實和準確的。每位內部人士聲明並保證該等內幕不受任何規定或 對任何法律訴訟、任何令的被告人， 停止 取消或拒絕任何與發售有關的行為或做法的命令或命令或規定 任何司法管轄區的證券；該類內人從未被定罪或承認罪 (i) 涉及欺詐、(ii) 與其他人的任何金融交易或處理資金有關的罪行，或 (iii) 有關 對任何證券進行交易，而該 Insider 目前並不是任何此類刑事訴訟中的被告；該內人從未被暫停或驅逐任何證券或商品交易所或協會的會員資格，或具有 證券或商品牌照或註冊被拒絕、暫停或撤銷。

3. 企業合併投票。它是 承認並同意，未經贊助商事先同意，本公司不得就擬議的業務合併訂立確定協議。贊助商及每位內部人士，就本身或本人而言， 同意，如果公司尋求股東批准建議的初始業務合併，則在與該建議的首次業務合併有關，該公司（如適用）應投票所有創始人股份、普通股 包括在私募配置單位及其持有的任何公開股份，適用於該建議初始股

 

2

業務合併（包括董事會建議與此類業務合併有關的任何建議）（不包括任何可能不獲贊成投票的公共股除外 根據規則的要求批准企業合併交易 14e-5 根據修訂的 1934 年證券交易法，以及任何委員會解釋或指引 有關），並不可在與該股東批准有關的情況下贖回其或其持有的任何公開股份。

4. 未完成企業合併；信託賬戶豁免.

(a) 贊助商及每位內部人士特此同意，在本公司的情況下，就本身或本人而言 若未在《約章》所訂明的期限內完成首次業務合併，贊助商及每位內部人士應採取一切合理措施，以使本公司 (i) 停止所有營運，除以下目的以外 清盤；(ii) 盡可能合理，但之後不超過 10 個工作日，以下方式贖回 100% 的公共股份 每股 價格，以現金支付，等於總金額 然後在信託帳戶存款時，包括信託賬戶中持有資金所獲得的利息（扣除提取或資格提取以資助本公司營運資本要求提取的金額，但每年限額為 25 萬美元（第」年提款能力」），只要任何未使用的年度提款能力將仍然可用於後續幾年提款，並增加後續年度提款能力 前幾年未使用的年度提款能力；及/或支付公司稅款（任何提款以支付公司稅金（不包括通脹所實施的 1％ 美國聯邦消費稅） 2022 年減免法（如果對本公司施行有任何）不受上述所述的年度提款能力限制約束）（此類提款，」允許提款」) 以及低至 10 萬美元的利息 支付解散費用），除以當時未發行的公共股份數目，贖回將完全消除公眾股東作為股東的權利（包括接受進一步清盤的權利） 派息（如有）；及 (iii) 在該等贖回後盡快，在公司其餘股東和董事會批准後盡快清算和解散，但在有條款的情況下，除非有條款而定 (ii) 及 (iii) 遵守本公司根據開曼群島法律規定的義務，在任何情況下都遵守適用法律的其他要求。贊助商及每位內部人士同意不提出任何修訂 《約章 (i) 修改本公司責任的內容或時間，就向公開股份持有人透過首次業務合併購股份或贖回 100％ 的權利 如本公司未在章程規定的時間內完成首次業務合併，或 (ii) 就有關公開股持有人權利的任何條文而言，除非 公司在股東獲股東批准後，在董事會在股東批准後實施任何該等修訂後，向其公開股東提供機會贖回其公開股份。 每股 價格， 以現金支付，等於當時存入信託帳戶的總金額，包括在信託帳戶中持有且先前未釋放進行允許提款的資金獲得利息，除以當時未償還的數目 公共股份。贊助商及每位內部人士承認並同意，任何根據認股證協議發行的任何認股證將不會從信託帳戶發出的發行，其所有權利將於 公司清盤。

 

3

(b) 贊助人及每位內部人應就其本身、她本人或他本人而言承認，在公司因创始股或普通股（如有）所含私募配售單元中持有的款項所屬信託賬戶的任何清盤而涉及時，均無權、標題、利益或任何類型的索賠。贊助人及每位內部人特此放棄其、她或他可能具有的任何创始股、私募配售單元中所包含的普通股及公眾股的贖回權（如適用）之權利，該等權利涉及（x）公司完成初次業務組合，以及（y）股東投票核准對章程進行修訂的情形，（i）該等修訂將修改公司對公眾股持有人提供在初次業務組合中有權贖回其股份或在公司未在章程中指定的期限內完成初次業務組合的情況下贖回100％公眾股的義務之實質或時間的條款，或（ii）關於任何涉及公眾股持有人權利的規定（儘管贊助人和內部人將有權就在公司未在章程中規定的要求期限內完成初次業務組合時持有的任何公眾股訴諸清算權利）。

5. 鎖定期限; 轉讓限制.

(a) 贊助人與內部人同意，不得在最早發生下列情形之前，即（A）公司完成初次業務組合後180天及（B）公司完成初次業務組合後的日期，該日期之後公司完成清算、合併、股份交換、重組或其他類似交易，導致所有普通股東有權將其普通股交換為現金、證券或其他財產（「創始人股份 鎖定期」)創始人股份 鎖定期 期間”).

(b) 根據所載規定 第5(d)段，贊助商和內部人同意在首次業務組合完成後30天內不進行任何定向增發單位及其中包含的證券的轉讓。

(c) 在承銷協議生效日起至該日期後180天結束的期間內，未經代表的事先書面同意，贊助商和每位內部人不得轉讓其持有的普通股或任何其他可轉換成或行使或兌換為普通股的證券，根據所載規定 第5(d)段 以及Underwriting Agreement第3(p)條列舉的特定例外情況。

儘管規定已訂明於 第5(a)款, (b) 和 (c)創始人股份、創始人股份下的任何普通股、定向增發單位以及定向增發單位包括的證券的轉讓，得允許：(a)給本公司的高級職員或董事、任何本公司高級職員或董事的關聯企業或家庭成員、特別目的收購人成員或合伙人或其關聯企業、特別目的收購人的關聯企業或其關聯企業的任何員工；(b)對於個人，透過贈與轉讓給個人直系家庭成員或託管給個人直系家庭成員為受益人的信託、此人的關聯企業，或慈善組織；(c)對於個人，根據繼承法的規定轉讓和分配

 

4

death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with the consummation of a Business Combination at prices no greater than the price at which the Founder Shares, Private Placement Units, Private Placement Warrants or Ordinary Shares, as applicable, were originally purchased; (f) pro rata distributions from the Sponsor to its members, partners, or shareholders pursuant to the Sponsor’s organizational documents; (g) by virtue of the Sponsor’s organizational documents upon liquidation or dissolution of the Sponsor; (h) to the Company for no value for cancellation in connection with the consummation of its initial Business Combination; (i) in the event of the Company’s liquidation prior to the completion of its initial Business Combination; or (j) in the event of completion of a liquidation, merger, share exchange or other similar transaction which results in all of the Company’s Public Shareholders having the right to exchange their Ordinary Shares for cash, securities or other property subsequent to the completion of an initial Business Combination; provided, however, that in the case of clauses (a) through (g) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions. For the avoidance of doubt, the transfers of Founder Shares, Private Placement Units, Private Placement Warrants and Ordinary Shares, including Ordinary Shares included in units or issued or issuable upon the exercise of the Private Placement Warrants or conversion of the Founder Shares shall be permitted regardless of whether a filing under Section 16(a) of the Exchange Act shall be required or shall be voluntarily made with respect to such transfers.

6. Remedies. The Sponsor and each of the Insiders hereby agree and acknowledge that (i) each of the Underwriters and the Company would be irreparably injured in the event of a breach by the Sponsor or an Insider of its, her or his obligations, as applicable under paragraphs 3, 4, 5, 8 and 9, (ii) monetary damages may not be an adequate remedy for such breach, and (iii) the non-breaching party shall be entitled to injunctive relief, in addition to any other remedy that such party may have in law or in equity, in the event of such breach.

7. Director and Officer Liability Insurance. The Company will maintain an insurance policy or policies providing directors’ and officers’ liability insurance, and the Insiders shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage available for any of the Company’s directors or officers.

8. Indemnification. In the event of the liquidation of the Trust Account upon the failure of the Company to consummate its initial Business Combination within the time period set forth in the Charter, the Sponsor (the “Indemnitor”) agrees to indemnify and hold harmless the Company against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, whether pending or threatened) to which the Company may become subject as a result of any claim by (i) any third party for services rendered or products sold to the Company (except for the Company’s independent auditors) or (ii) any prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”); provided, however, that such indemnification of the Company by the Indemnitor (x) shall apply only to the extent necessary to ensure that such claims by a third party for services rendered or products sold to the Company or a Target do not reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to reductions in the

 

5

value of the trust assets, in each case net of interest that may be withdrawn for Permitted Withdrawals, (y) shall not apply to any claims by a third party or Target who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) and (z) shall not apply to any claims under the Company’s indemnity of the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended. In the event that an executed waiver is deemed to be unenforceable against a third party, the Indemnitor will not be responsible to the extent of any liability for such third-party or Target claims. The Indemnitor shall have the right to defend against any such claim with counsel of its choice reasonably satisfactory to the Company if, within 15 days following written receipt of notice of the claim to the Indemnitor, the Indemnitor notifies the Company in writing that it shall undertake such defense.

9. Forfeiture of Founder Shares. To the extent that the Underwriters do not exercise their option to purchase additional Public Units within 45 days from the date of the Prospectus in full (as further described in the Prospectus), the Sponsor agrees to automatically surrender to the Company for no consideration, for cancellation at no cost, an aggregate number of Founder Shares so that the number of Founder Shares will equal of 20% of the sum of the total number of Ordinary Shares (excluding the Ordinary Shares included in the Private Placement Units) and Founder Shares outstanding at such time. The Sponsor and Insiders further agree that to the extent that the size of the Public Offering is increased or decreased, the Company will effect a share capitalization or a share repurchase, as applicable, with respect to the Founder Shares immediately prior to the consummation of the Public Offering in such amount as to maintain the number of Founder Shares at 20% of the sum of the total number of Ordinary Shares (excluding the Ordinary Shares included in the Private Placement Units) and Founder Shares outstanding at such time.

10. Entire Agreement. This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument executed by (1) each Insider with respect to herself or himself, as applicable, to the extent she or he are the subject of any such change, amendment, modification or waiver, (2) the Company, and (3) the Sponsor. Changes, amendments, modifications or waivers to paragraph 5(c) pursuant to the immediately foregoing sentence (other than to correct a typographical error) shall also require the written consent of the Representatives.

11. Assignment. No party hereto may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior written consent of the other parties. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on the Sponsor and each of the Insiders and each of their respective successors, heirs, personal representatives and assigns and permitted transferees.

12. Third-Party Rights. Except as provided for in paragraph 6, nothing in this Letter Agreement under the Contracts (Rights of Third Parties) Act (As Revised), as amended,

 

6

modified, re-enacted or replaced shall be construed to confer upon, or give to, any person or corporation other than the parties hereto any right, remedy or claim under or by reason of this Letter Agreement or of any covenant, condition, stipulation, promise or agreement hereof. Except as provided for in paragraph 6, all covenants, conditions, stipulations, promises and agreements contained in this Letter Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors, heirs, personal representatives and assigns and permitted transferees. Notwithstanding any other term of this Letter Agreement, the consent of any person who is not a party to this Letter Agreement is not required for any amendment to, or variation, release, rescission or termination of this Letter Agreement.

13. Counterparts. This Letter Agreement may be executed in any number of original or facsimile counterparts, and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. Delivery by portable document format (PDF) of any executed counterpart of this Letter Agreement shall be equally as effective as delivery of a manually executed counterpart thereof. Any party delivering an executed counterpart by PDF shall also deliver a manually executed counterpart of this Letter Agreement, but failure to do so shall not affect the validity, enforceability or binding effect of this Letter Agreement.

14. Effect of Headings. The paragraph headings herein are for convenience only and are not part of this Letter Agreement and shall not affect the interpretation thereof.

15. Severability. This Letter Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Letter Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

16. Governing Law. This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the Cayman Islands. The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced in the courts of the Cayman Islands, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive, and (ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum.

17. Notices. Any notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or facsimile or other electronic transmission.

18. Termination. This Letter Agreement shall terminate on the earlier of (i) the expiration of the Founder Shares Lock-up Period and (ii) the liquidation of the Company; provided, however, that this Letter Agreement shall terminate in the event that the Public Offering is not consummated and closed by December 31, 2024; provided further that paragraph 8 and paragraphs 10 through 18 of this Letter Agreement shall survive such liquidation.

 

7

[Signature Page Follows]

 

8

 

[Signature Page to Letter Agreement]

 

[Signature Page to Letter Agreement]

 

[Signature Page to Letter Agreement]

 

[Signature Page to Letter Agreement]

 

[Signature Page to Letter Agreement]

 

[Signature Page to Letter Agreement]

 

[Signature Page to Letter Agreement]

 

[Signature Page to Letter Agreement]

 

[Signature Page to Letter Agreement]